Cancer Statistics: Global and National

  • Mary J. Milroy


Cancer is the second leading cause of death throughout the world, second only to cardiovascular disease. Globally, in 2015, there were 17.5 million cancer cases and 8.7 million deaths. From 2005 to 2015, the number of cancer cases rose by 33%. The Global Burden of Disease Cancer Collaboration attributed this increase to population aging 16%, population growth 13%, and changes in age-specific rates 4%. In the United States, the American Cancer Society predicts 1,688,780 new cases of cancer with 600,920 Americans expected to die of cancer in 2017. The identification of modifiable risk factors is of prime importance in the effort to decrease both cancer-related mortality and disability. The prime risk factors identified are exposure to tobacco, high body mass index, lack of physical activity, low fruit and vegetable intake, alcohol use, exposure to ultraviolet radiation, and chronic viral infection. This literature review looks at the increasing prevalence of cancer throughout the world and some of the modifiable risk factors for cancer prevention.


Cancer Aging and cancer Modifiable risk factors and cancer incidence 


  1. 1.
    Mukherjee S. The emperor of all maladies, a biography of cancer. Scr Theol. 2011:40–1.Google Scholar
  2. 2.
    Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Li D, de Glas NA, Hurria A. Cancer and aging: General principles, biology, and geriatric assessment. Clin Geriatr Med. 2016;32(1):1–15.CrossRefPubMedGoogle Scholar
  4. 4.
    Serrano M. Unraveling the links between cancer and aging. Carcinogenesis. 2016;37(2):107.CrossRefPubMedGoogle Scholar
  5. 5.
    WHO: Number of people over 60 years set to double by 2050; major societal changes required.
  6. 6.
    WHO Cancer Fact sheet updated February 2017. 2017.
  7. 7.
    Siegel R, Miller K, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.CrossRefGoogle Scholar
  8. 8.
  9. 9.
  10. 10.
    Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Oncol. 2012;4(9):e609–16.Google Scholar
  11. 11.
    CDC-Fact Sheet. Current cigarette smoking among adults in the U.S.
  12. 12.
    Kushi L, Doyle C, McCullough M, Rock C, Demark-Wahnefried W, Bandera E, et al. ACS Guidelines on nutrition and physical activity for cancer prevention. CA Cancer J Clin. 2012;62(1):30–67.CrossRefPubMedGoogle Scholar
  13. 13.
    NCD Risk Factor Collaboration. Trends in adult body mass index in 200 countries from 1975 to 2014: a pooled analysis of 1678 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.CrossRefGoogle Scholar
  14. 14.
    Boffetta P, Couto E, Wichmann J, Ferrari P, Trichopoulos D, Bueno-de-Mesquita HB, et al. Fruit and vegetable intake and overall cancer risk in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst. 2010;102(8):529–37.CrossRefPubMedGoogle Scholar
  15. 15.
    Montague M, Borland R, Sinclair C. Sun smart-twenty years on 1980 to 2000: skin cancer control and 20 years of population based campaigning. Health Educ Behav. 2001;28(3):290–305.CrossRefPubMedGoogle Scholar
  16. 16.
    Ringehan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372(1732):20160274.CrossRefGoogle Scholar
  17. 17.
    Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10 Suppl):3036–46.CrossRefPubMedGoogle Scholar
  20. 20.
    Drolet M, Benard E, Boily MC, Ali H, Baandrup L, Bauer H, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565–80. Epub 2015 Mar 3CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state and selected area vaccination coverage among adolescents aged 13-17 years-United States 2015. MMWR Morb Mortal Wkly Rep. 2016;65:850–8.CrossRefPubMedGoogle Scholar
  22. 22.
    McCullough ML, Patel AV, Kushi LH, Patel R, Willett W, Doyle C, et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomark Prev. 2011;20(6):1089–97.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Mary J. Milroy
    • 1
  1. 1.Department of Surgery, Sanford School of MedicineUniversity of South DakotaVermillionUSA

Personalised recommendations